Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-11-15

FDA Approved: DAPTOMYCIN — Original Application (Sagent Pharmaceuticals)

View source ↗

Summary

FDA approved the original application for daptomycin by Sagent Pharmaceuticals, authorizing a generic injectable form of daptomycin.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Daptomycin (daptomycin)

Snippet

ORIG AP for DAPTOMYCIN (DAPTOMYCIN)